Monopar Therapeutics Income Statement (2016-2026) | MNPR

Income Statement Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating items
Research & Development (Quarter)
1.48M1.83M1.98M1.68M2.08M1.73M2.10M1.65M1.59M1.32M0.97M1.13M0.98M1.52M1.64M1.73M2.59M4.77M
Selling, General & Administrative (Quarter)
0.62M0.63M0.70M0.78M0.68M0.68M0.81M0.87M0.73M0.75M0.76M0.66M0.59M1.58M1.50M1.50M1.88M
Other Operating Expenses (Quarter)
-1.00
Operating Expenses (Quarter)
2.09M2.46M2.68M2.46M2.76M2.41M2.91M2.53M2.33M2.07M1.72M1.79M1.57M1.52M3.22M3.23M4.09M6.64M
Operating Income (Quarter)
-2.09M-2.46M-2.68M-2.46M-2.76M-2.41M-2.91M-2.53M-2.33M-2.07M-1.72M-1.79M-1.57M-3.22M-3.23M-4.09M-6.64M
EBIT (Quarter)
-2.09M-2.46M-2.68M-2.46M-2.76M-2.41M-2.91M-2.53M-2.33M-2.07M-1.72M-1.79M-1.57M-3.22M-3.23M-4.09M-6.64M
Non-operating items
Non Operating Investment Income (Quarter)
0.03M
Interest & Investment Income (Quarter)
0.63M0.03M-0.02M0.11M0.80M0.02M0.00M0.10M346.000.78M-0.07M1.30M
Other Non Operating Income (Quarter)
0.17M0.03M
Net income details
EBT (Quarter)
-2.09M-2.46M-10.40M-2.46M-2.85M-2.41M-13.42M-2.49M-2.35M-1.95M-1.70M-1.79M-1.48M-3.22M-2.58M-4.27M-5.57M
Profit After Tax (Quarter)
-57.00-2.46M-2.68M-2.46M-2.76M-2.37M-2.88M-2.43M-2.20M-1.96M-1.64M-1.72M-1.30M-2.62M-2.45M-3.50M-5.32M
Income from Continuing Operations (Quarter)
-2.09M-2.46M-10.40M-2.46M-2.85M-2.41M-13.42M-2.49M-2.35M-1.95M-1.70M-1.79M-1.48M-3.22M-2.58M-4.27M-5.57M
Consolidated Net Income (Quarter)
-2.09M-2.46M-10.40M-2.46M-2.85M-2.41M-13.42M-2.49M-2.35M-1.95M-1.70M-1.79M-1.48M-3.22M-2.58M-4.27M-5.57M
Income towards Parent Company (Quarter)
-2.09M-2.46M-10.40M-2.46M-2.85M-2.41M-13.42M-2.49M-2.35M-1.95M-1.70M-1.79M-1.48M-3.22M-2.58M-4.27M-5.57M
Net Income towards Common Stockholders (Quarter)
-2.09M-2.46M-10.40M-2.46M-2.85M-2.41M-13.42M-2.49M-2.35M-1.95M-1.70M-1.79M-1.48M-3.22M-2.58M-4.27M-5.57M
Additional items
EPS (Basic) (Quarter)
-0.83-0.98-4.17-0.98-1.13-0.95-5.28-0.95-0.87-0.69-0.53-0.51-0.42-0.46-0.37-0.60-0.75
Shares Outstanding (Quarter)
2.51M2.52M2.49M2.52M2.53M2.55M2.54M2.62M2.68M2.82M2.76M3.20M3.50M3.52M3.79M6.99M7.00M7.12M7.41M7.41M
Shares Outstanding (Entity) (Quarter)
2.52M2.52M2.52M2.52M2.54M2.57M2.59M2.64M2.78M2.84M2.98M3.50M3.52M3.53M3.79M6.12M6.13M6.66M6.69M8.54M
EBITDA (Quarter)
-2.09M-2.46M-2.68M-2.46M-2.76M-2.41M-2.91M-2.53M-2.33M-2.07M-1.72M-1.79M-1.57M-3.22M-3.23M-4.09M-6.64M
Interest Expenses (Quarter)
7.72M0.00M0.08M0.00M11.14M13.27M17.87M4.000.12M0.11M0.02M0.22M